Comparative Effectiveness of Three Ovarian Hyperstimulation Protocol in In Vitro Fertilization (IVF) Cycles for Women with Polycystic Ovary Syndrome

被引:5
|
作者
Chen, Yilu [1 ]
Zhao, Junzhao [1 ]
Zhang, Huina [1 ]
机构
[1] Wenzhou Med Univ, Reprod Ctr, Dept Obstet & Gynaecol, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2018年 / 24卷
关键词
Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; BASAL LUTEINIZING-HORMONE; REVISED; 2003; CONSENSUS; DIAGNOSTIC-CRITERIA;
D O I
10.12659/MSM.913757
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The aim of this study was to evaluate the efficacy of specific in vitro fertilization (IVF) protocols for patients with polycystic ovary syndrome (PCOS), and therefore, analyze the first-rank intention IVF protocol. Material/Methods: In this study, 408 PCOS patients (464 treatment cycles) were enrolled and assigned to one of 3 groups: group 1 [oral contraceptive long-term regimen group (OC-L protocol group, n=91)], group 2 (GnRH antagonist protocol, n=80), and group 3 [follicular phase long-term regimen group, C-1-L protocol group n=293]. The endpoints are the number of eggs, oocyte maturation rate, high-quality embryo rate and clinical pregnancy rate after fresh embryos transfer, the incidence of ovarian hyperstimulation syndrome and abortion rate. Results: The number of eggs, oocyte maturation rate, and high-quality embryo rate in the C-1-L protocol group were significantly higher than those in the other 2 groups. The fertilization rate and cleavage rate of the 3 groups were not significantly different. After fresh embryo transplantation, the pregnancy rate of C-1-L protocol group was significantly higher than that of the other groups. Conclusions: This study showed that the super-long downregulation in follicular phase regimen has advantages of simple treatment process, high oocyte maturation rate, high quality embryo rate, and pregnancy rate. It is a good choice for PCOS patients to promote ovulation during IVF.
引用
收藏
页码:9424 / 9428
页数:5
相关论文
共 50 条
  • [41] In vitro fertilization outcomes in women with polycystic ovary syndrome: A meta-analysis
    Tang, Kefu
    Wu, Lei
    Luo, Ying
    Gong, Bo
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2021, 259 : 146 - 152
  • [42] The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles
    Owj, M
    Tehrani-Nejad, ES
    Amirchaghmaghi, E
    Baghestani, AR
    Ahmadi, J
    [J]. SAUDI MEDICAL JOURNAL, 2005, 26 (10) : 1584 - 1587
  • [43] Unilateral Ovarian Torsion in Triplex Pregnancy after Ovarian Hyperstimulation and in Vitro Fertilization (IVF)
    Da Costa, Andre Luiz Eigenheer
    Sene, Ingridi Sousa
    [J]. JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2005, 9 (04): : 27 - 32
  • [44] Vascular endothelial growth factor, polycystic ovary syndrome, and ovarian hyperstimulation syndrome
    Meldrum, DR
    [J]. FERTILITY AND STERILITY, 2002, 78 (06) : 1170 - 1171
  • [45] Comparison of the first three cycles of in vitro fertilization (IVF):: Are success rates different for women using IVF in subsequent cycles?
    Ambartsumyan, G
    Huang, A
    Decherney, A
    [J]. FERTILITY AND STERILITY, 2004, 82 : S216 - S217
  • [46] Are polyfluoroalkyl chemicals associated with raised levels of serum testosterone in women with and without Polycystic Ovary Syndrome, undergoing controlled ovarian hyperstimulation IVF cycle
    Cunningham, T.
    Drage, D.
    Allgar, V.
    Kilpatrick, E.
    Maguiness, S.
    Mueller, J.
    Atkin, S.
    Sathyapalan, T.
    [J]. HUMAN REPRODUCTION, 2016, 31 : 453 - 454
  • [47] OVARIAN HYPERSTIMULATION IN POLYCYSTIC OVARY SYNDROME DURING THERAPY WITH LEUPROLIDE ACETATE
    WALMER, DK
    HANEY, AF
    DODSON, WC
    [J]. FERTILITY AND STERILITY, 1989, 52 (05) : 858 - 859
  • [48] In vitro fertilization in the polycystic ovary syndrome patient: An update
    Lin, Kathleen
    Coutifaris, Christos
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2007, 50 (01): : 268 - 276
  • [49] Polycystic ovary syndrome: Pathophysiology and outcome with in vitro fertilization
    Buyalos, RP
    Lee, CT
    [J]. FERTILITY AND STERILITY, 1996, 65 (01) : 1 - 10
  • [50] The usage of Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
    Zhu, X.
    Fu, Y.
    [J]. HUMAN REPRODUCTION, 2016, 31 : 420 - 421